LONDON (REUTERS) - Britain said on Friday (Aug 28) it will back three nationwide Covid-19 studies with 8.4 million pounds (S$15.1 million) to fund research into understanding human immune responses to the pandemic coronavirus.. Read more at straitstimes.com.
LONDON - Britain said on Friday it will back three nationwide Covid-19 studies with 8.4 million pounds to fund research into understanding human immune responses to the pandemic coronavirus.
"Together, it is hoped these studies will improve the treatment of patients and inform the development of vaccines and therapies," the funding bodies said in a joint statement.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US core capital goods orders rise; recovery uneven as COVID-19 shifts spendingNew orders for key US-made capital goods increased in July, though the pace slowed from June's robust gain, suggesting the rebound in business ...
Read more »
Silverlake Axis Q4 net profit down 12%, with Covid-19 hampering deal closureFINTECH firm Silverlake Axis saw net profit fall 12 per cent to RM59.1 million (S$19.4 million) for the fourth quarter ended June 30, as the Covid-19 pandemic hampered the timely closing of deals, the firm said in its results release on Tuesday after the market closed. Read more at The Business Times.
Read more »
Thailand delays human testing for COVID-19 vaccineThailand will delay human trials of its coronavirus vaccine due to limited production capacity at overseas facilities, a senior official said on ...
Read more »
60 new Covid-19 infections in Singapore, including 10 imported cases and 3 in the communitySINGAPORE — Singapore has confirmed 60 new cases of Covid-19, said the Ministry of Health (MOH) in a press release on Wednesday (Aug 26).
Read more »
Record infections, few deaths: How Qatar has tackled Covid-19DOHA, Qatar — Qatar has the world's highest per-capita coronavirus infection rate but one of the lowest death rates, due to extensive testing, a young population and lavish healthcare spending.
Read more »